Neurobiology of Aging
Volume 28, Issue 8 , Pages 1163-1169 , August 2007

Lymphocyte subset patterns and cytokine production in Alzheimer's disease patients

  • Livianna Speciale

      Affiliations

    • Laboratory of Molecular Medicine and Biotechnologies, Don Gnocchi Foundation, ONLUS, IRCCS, Via Capecelatro 66, I-20148 Milan, Italy
    • ,
  • Elena Calabrese

      Affiliations

    • Department of Neurological Rehabilitation, Don Gnocchi Foundation, ONLUS, IRCCS, Milan, Italy
    • ,
  • Marina Saresella

      Affiliations

    • Laboratory of Molecular Medicine and Biotechnologies, Don Gnocchi Foundation, ONLUS, IRCCS, Via Capecelatro 66, I-20148 Milan, Italy
    • ,
  • Carmine Tinelli

      Affiliations

    • Biometric Unit, IRCCS, S. Matteo Hospital, Pavia, Italy
    • ,
  • Claudio Mariani

      Affiliations

    • Chair of Neurology, L. Sacco Hospital, University of Milan, Milan, Italy
    • ,
  • Lara Sanvito

      Affiliations

    • Department of Neurological Rehabilitation, Don Gnocchi Foundation, ONLUS, IRCCS, Milan, Italy
    • ,
  • Renato Longhi

      Affiliations

    • National Research Council Institute of Chemistry of Molecular Recognition, Milan, Italy
    • ,
  • Pasquale Ferrante

      Affiliations

    • Laboratory of Molecular Medicine and Biotechnologies, Don Gnocchi Foundation, ONLUS, IRCCS, Via Capecelatro 66, I-20148 Milan, Italy
    • Chair of Virology, Department of Biomedical Sciences and Technology, University of Milan, Milan, Italy
    • Corresponding Author InformationCorresponding author . Tel.: +39 02 40308426; fax: +39 02 40308539.

Received 26 January 2006 ,Revised 17 May 2006 ,Accepted 18 May 2006.

References 

  1. Akdis CA, Blaser K. Mechanism of interleukin-10-mediated immune suppression. Immunology. 2001;103:131–136
  2. Antonaci S, Tortorella C, Polignano A, Ottolenghi A, Jirillo E, Bonomo L. Modulating effects on CD25 and CD71 antigen expression by lectin-stimulated T lymphocytes in the elderly. Immunopharmacol Immunotoxicol. 1991;13:87–100
  3. Atherton E, Sheppard RC . In:  Udenfriend S,  Meienhofer J editor. The Peptides. vol. 9:San Diego, CA: Academic Press; 1987;p. 1–39
  4. Caruso A, Licenziati S, Corulli M, Canaris AD, De Francesco MA, Fiorentini S, et al. Flow cytometric analysis of activation markers on stimulated T cells and their correlation with cell proliferation. Cytometry. 1997;27:71–76
  5. Castle SC, Uyemura K, Crawford W, Wong W, Klaustermeyer WB, Makinodan T. Age-related impaired proliferation of peripheral blood mononuclear cells is associated with an increase in both IL-10 and IL-12. Exp Gerontol. 1999;34:243–252
  6. Cortesini R, LeMaoult J, Ciubotariu R, Suciu-Foca N. CD8+CD28− T suppressor cells and the induction of antigen-specific, antigen-presenting cell-mediated suppression of Th reactivity. Immunol Rev. 2001;182:201–206
  7. Effros RB. Loss of CD28 expression on T lymphocytes: a marker of replicative senescence. Dev Comp Immunol. 1997;21:471–478
  8. Fagnoni FF, Vescovini R, Mazzola M, Bologna G, Nigro E, Lavagetto G, et al. Expansion of cytotoxic CD8+CD28− T cells in healthy aging people, including centenarians. Immunology. 1996;88:501–507
  9. Fields GB, Noble RL. Solid phase peptide synthesis utilizing 9-fluorenylmethoxycarbonyl amino acids. Int J Peptide Protein Res. 1990;35:161–214
  10. Fischer P, Gotz ME, Danielczyk W, Gsell W, Riederer P. Blood transferrin and ferritin in Alzheimer's disease. Life Sci. 1997;60:2273–2278
  11. Folstein MF, Folstein SE, McHugh PR. “Mini-mental state” a practical method for grading the cognitive state of patients for the clinicians. J Psychiatr Res. 1975;12:189–198
  12. Gitter BD, Cox LM, Rydel LE, May PC. Amyloid β peptide potentiate cytokine secretion by interleukin 1-β-activated human astrocytoma cell. Proc Natl Acad Sci. 1995;92:10738–10741
  13. Ligthart GJ, Corberand JX, Fournier C, Galanaud P, Hijmans W, Kennees B, et al. Admission criteria for immunogerontological studies in man: the Senieur protocol. Mech Ageing Dev. 1984;28:47–55
  14. Lio D, Candore G, Cigna D, D’Anna C, Di Lorenzo G, Giordano C, et al. In vitro T cell activation in elderly individuals: failure in CD69 and CD71 expression. Mech Ageing Dev. 1996;89:51–58
  15. Lio D, Scola L, Crivello A, Colonna Romano G, Candore G, Bonafe M, et al. Gender-specific association between -1082 IL-10 promoter polymorphism and longevity. Genes Immunol. 2002;3:30–33
  16. Lombardi VR, Garcia M, Rey L, Cacabelos R. Characterization of cytokine production, screening of lymphocyte subset patterns and in vitro apoptosis in healthy and Alzheimer's Disease (AD) individuals. J Neuroimmunol. 1999;97:163–171
  17. Ma SL, Tang NL, Lam LC, Chiu HF. The association between promoter polymorphism of the interleukin-10 gene and Alzheimer's disease. Neurobiol Aging. 2005;7:1005–1010
  18. Martin-Romero C, Santos-Alvarez J, Goberna R, Sanchez-Margalet V. Human leptin enhances activation and proliferation of human circulating T lymphocytes. Cell Immunol. 2000;199:15–24
  19. McGeer PL, Klegeris A, Walker DG, Yasuhara O, McGeer EG. Pathological proteins in senile plaques. Tohoku J Exp Med. 1994;174:269–277
  20. McKhann G, Drachman D, Folstein M, Katzman R, Price D, Stadlan EM. Clinical diagnosis of Alzheimer's Disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Service Task Force on Alzheimer's Disease. Neurology. 1984;34:939–944
  21. Meda L, Bonaiuto C, Szendrei GI, Ceska M, Rossi F, Cassatella MA. Beta-Amyloid(25–35) induces the production of interleukin-8 from human monocytes. J Neuroimmunol. 1995;59:29–33
  22. Akiyama H, Barger S, Barnum S, Bradt B, Bauer J, Cole GM, et al. Inflammation and Alzheimer's disease. Neurobiol Aging. 2000;21(3):383–421
  23. Paganelli R, Quinti I, Fagiolo U, Cossarizza A, Ortolani C, Guerra E, et al. Changes in circulating B cells and immunoglobulin classes and subclasses in a healthy aged population. Clin Exp Immunol. 1992;90:351–354
  24. Pike CJ, Burdick D, Walencewicz AJ, Glabe CG, Cotman CW. Neurodegeneration induced by beta-amyloid peptides in vitro: the role of peptide assembly state. J Neurosci. 1993;13:1676–1687
  25. Posnett DN, Edinger JW, Manavalan JS, Irwin C, Marodon G. Differentiation of human CD8 T cells: implications for in vivo persistence of CD8+CD28− cytotoxic effector clones. Int Immunol. 1999;11:229–241
  26. Rea IM, Steward M, Campbell P, Alexander HD, Crockard AD, Morris TC. Changes in lymphocyte subsets, interleukin 2, and soluble interleukin 2 receptor in old and very old age. Gerontology. 1996;42:69–78
  27. Remarque EJ, Bollen EL, Weverling-Rijnsburger AW, Laterveer JC, Blauw GJ, Westendorp RG. Patients with Alzheimer's disease display a pro-inflammatory phenotype. Exp Gerontol. 2001;36:171–176
  28. Shalit F, Sredni B, Brodie C, Kott E, Huberman M. T lymphocyte subpopulations and activation markers correlate with severity of Alzheimer's disease. Clin Immunol Immunopathol. 1995;75:246–250
  29. Shoji M, Kanai M. Cerebrospinal fluid Abeta40 and Abeta42: natural course and clinical usefulness. J Alzheimers Dis. 2001;3:313–321
  30. Singh VK, Guthikonda P. Circulating cytokines in Alzheimer's disease. J Psychiatr Res. 1997;31:657–660
  31. Solerte SB, Cravello L, Ferrari E, Fioravanti M. Overproduction of IFN-gamma and TNF-α from natural killer (NK) cells is associated with abnormal NK reactivity and cognitive derangement in Alzheimer's disease. Ann NY Acad Sci. 2000;917:331–340
  32. Suciu-Foca N, Manavalan JS, Scotto L, Kim-Schulze S, Galluzzo S, Naiyer AJ, et al. Molecular characterization of allospecific T suppressor and tolerogenic dendritic cells: review. Int Immunopharmacol. 2005;1:7–11
  33. Speciale L, Ruzzante S, Calabrese E, Saresella M, Taramelli D, Mariani C, et al. 1–40 β-amyloid protein fragment modulates the expression of CD44 and CD71 on the astrocytoma cell line in the presence of IL1β and TNF-α. J Cell Physiol. 2003;196:190–195
  34. Stephan RP, Reilly CR, Witte PL. Impaired ability of bone marrow stromal cells to support B-lymphopoiesis with age. Blood. 1998;91:75–88
  35. Strazielle N, Ghersi-Egea JF, Ghiso J, Dehouck MP, Frangione B, Patlak C, et al. In vitro evidence that beta-amyloid peptide 1–40 diffuses across the blood-brain barrier and affects its permeability. J Neuropathol Exp Neurol. 2000;59:29–38
  36. Tan J, Town T, Abdullah L, Wu Y, Placzek A, Small B, et al. CD45 isoform alteration in CD4+T cells as a potential diagnostic marker of Alzheimer's disease. J Neuroimmunol. 2002;132:164–172
  37. Van Muiswinkel FL, Raupp SF, de Vos NM, Smits HA, Verhoef J, Eikelenboom P, et al. The amino-terminus of the amyloid-beta protein is critical for the cellular binding and consequent activation of the respiratory burst of human macrophages.. J Neuroimmunol. 1999;96(1):121–130
  38. Wick G, Grubeck-Loebenstein B. The aging immune system: primary and secondary alterations of immune reactivity in the elderly. Exp Gerontol. 1997;32:401–413

PII: S0197-4580(06)00180-1

doi: 10.1016/j.neurobiolaging.2006.05.020

Neurobiology of Aging
Volume 28, Issue 8 , Pages 1163-1169 , August 2007

Article Tools

* Image Usage & Resolution